NIH

Title: Small Business Innovation Research Program–Grant
Sponsor:  National Institute of Neurological Disorders and Stroke/NIH/DHHS

SYNOPSIS:    National Institute of Neurological Disorders and
Stroke (NINDS) invites eligible United States small business concerns
(SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track (NIH only), and Phase IIB Competing Renewal (NIH
only) grant applications for innovative neuroscience research or neuroscience research and development (R/R&D) that has both the potential for commercialization and public benefit.  United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, FDA or ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see:
http://grants.nih.gov/grants/funding/sbirsttr1/2014-2_SBIR-STTR-topics
.pdf
).  This FOA will utilize the NIH R43/R44 Small Business Innovation Research (SBIR) Grant – Phase I, Phase II, and Fast-Track award mechanisms.

Deadline(s):      04/05/2014
05/07/2014
08/05/2014
09/07/2014
12/05/2014
01/07/2015
Established Date: 01/21/2014
Follow-Up Date:   02/01/2015
Review Date:      01/21/2014

Contact:          Ms. Stephanie Fertig

Address:          6001 Executive Boulevard Suite 3309
Bethesda, MD 20892-9531
U.S.A.
E-mail:           fertigs@ninds.nih.gov
Web Site: http://grants1.nih.gov/grants/guide/pa-files/PA-14-071.html
Program URL: http://grants.nih.gov/grants/funding/sbirsttr1/2014-2_SBIR-STTR-topics.pdf
Tel:              301-496-1779
Fax:              301-402-1501
Deadline Ind:     Receipt
Deadline Open:    No

DEADLINE NOTE
Applications may be submitted to Grants.gov in response to this announcement on or after March 5, 2014. The deadlines for receipt of standard applications under this announcement are: April 5, August 5 and December 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015.

Award Type(s):    Small Business Innovation Research

Citizenship/Country of Applying Institution:
U.S.A. Citizenship (including U.S. Territories)
U.S. Permanent Resident

Locations Tenable:    U.S.A. Institution (including U.S. Territories)

Appl Type(s):     For-Profit
Small Business

Target Group(s):  NONE
Funding Limit:    $0   SEEBELOW
Duration:         0
Indirect Costs:   Yes
Cost Sharing:     No
Sponsor Type:     NONE

Geo. Restricted:  NO RESTRICTIONS

CFDA#:

OBJECTIVES:   The purpose of the SBIR Program is to stimulate
technological innovation in the private sector, strengthen the role of small business in meeting federal research or research and development
(R/R&D) needs, increase the commercial application of sponsor-supported research results, foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns in technological innovation. The objective of Phase I is to establish the technical/scientific merit and feasibility of the proposed R/R&D efforts in the development of
projects that have potential for commercialization.   Research
topics are: therapeutics and diagnostics development for neurological disorders; technology and tools; clinical trials; and countermeasures against chemical threats. In addition to the specified research topics, grant applications will be considered in any area within the mission of the sponsor.

ELIGIBILITY
Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit; is (a) at least fifty-one percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or
(b) for SBIR only, it must be a for-profit business concern that is at least fifty-one percent owned and controlled by another for-profit business concern that is at least fifty-one percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States; and has, including its affiliates, an average number of employees for the preceding twelve months not exceeding 500.  Small business concerns that are more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms are now eligible to apply
to NIH only.   More than one PD/PI, or multiple PDs/PIs, may be
designated on the application for projects that require a ?team science? approach that clearly does not fit the single-PD/PI model.  Under the SBIR program, for both Phase I and Phase II, the primary employment of the PD/PI must be with the small business concern at the time of award and during the conduct of the proposed project. For projects with multiple PD/PIs, at least one must meet the primary employment requirement and will be referred to as the ?small business PD/PI.? Primary employment means that more than one half of the PD/PI?s time is spent in the employ of the small business concern.

FUNDING
This FOA will utilize the NIH R43/R44 Small Business Innovation Research (SBIR) Grant – Phase I, Phase II, and Fast-Track award
mechanisms.   According to statutory guidelines, total funding support
(direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards.  With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% ($225,000 for Phase I and
$1,500,000 for Phase II, a hard cap). NIH has received a limited waiver from SBA, as authorized by the statute, to exceed the hard cap for specific topics. Due to the nature of the waiver, some NIH Institutes and Centers generally will not consider applications with budgets over $225,000 for Phase I and $1,500,000 for Phase II. Please refer to the appropriate Institute?s or Center?s topic section to determine whether they will consider applications above these amounts.
Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the hard cap
($225,000 for Phase I and $1,500,000 for Phase II). In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the research project.  According to statutory guidelines, award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for
completion of the research project.     Reference: NIH Guide,
Week Ending January 17, 2014. (kww)

KEYWORDS:         Cognitive Development/Processes
Rehabilitation/Therapy
Brain
Nervous System
Neurological Disorders
Stroke
Neural Stimulation
Neurology
Neuroscience
Chemical Effects
Technology
Biological/Chemical Warfare
Neurodegenerative Diseases/Disorders
Innovation
Bioterrorism
Neuroimaging
Translational Research
Grants.gov
Grants.gov/S2S